CA

Casma Therapeutics

3 known investors

casmatx.com ↗

Casma Therapeutics develops therapies based on targeted autophagy, using its PHLYT (Phagosome-Lysosome Targeting) platform to initiate target-specific degradation of disease-causing cellular components regardless of size or complexity. The company aims to treat diseases that current drugs have not been able to target.

Investors · 3

AS

Astellas Venture Management LLCSouth San Francisco · $200K – $5M

EI

Eisai Innovation, Inc.San Francisco

ON

Ono Venture Investment, Inc.South San Francisco